Peer-reviewed Articles
AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):39-48.
Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon.
Tebit DM, Zekeng L, Kaptué L, Salminen M, Kräusslich HG, Herchenröder O.Mol Cell Neurosi. 2001; 17:68-79.
Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor.
Rega S, Stiewe T, Chang D-I, Pollmeier B, Esche H, Bardenheuer W, Marquitan G, Pützer BM.J Natl Cancer Inst. 2001; 93:472-479.
Large Nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin-12/B7.1 genes.
Pützer BM, Stiewe T, Rödicker F, Schildgen O, Rühm S, Dirsch O, Fiedler M, Dahmen U, Tennant B, Scherer C, Graham FL, Roggendorf M.Cancer Res. 2001; 61:7052-7055.
Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction.
Rödicker F, Stiewe T, Zimmermann S, Pützer BM.Virology. 2001 Sep 15;288(1):139-44.
Low-level expression of functional foamy virus receptor on hematopoietic progenitor cells.
von Laer D, Lindemann D, Roscher S, Herwig U, Friel J, Herchenröder O.Nat Genet. 2000; 26:464-469.
Role of the p53-homolog p73 in E2F1-induced apoptosis.
Stiewe T, Pützer BM.Gene Ther. 2000; 7:1317-1325.
Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
Pützer BM, Stiewe T, Crespo F, Esche H.Cell Death Differ. 2000; 7:177-188.
E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products.
Pützer BM, Stiewe T, Parssanedjad K, Rega S, Esche H.Tumor Diag Ther. 2000; 21:1-7.
The Role of Tumor Suppressor Gene Therapy for Anticancer Treatment.
Pützer BM.2000
Abstract